NasdaqGM - Delayed Quote USD

Biora Therapeutics, Inc. (BIOR)

0.6277 +0.0207 (+3.41%)
At close: April 26 at 4:00 PM EDT
0.6372 +0.01 (+1.51%)
After hours: April 26 at 7:30 PM EDT
Key Events
Loading Chart for BIOR
DELL
  • Previous Close 0.6070
  • Open 0.6334
  • Bid 0.6199 x 300
  • Ask 0.6322 x 300
  • Day's Range 0.6045 - 0.6334
  • 52 Week Range 0.5850 - 6.7000
  • Volume 127,941
  • Avg. Volume 438,769
  • Market Cap (intraday) 22.452M
  • Beta (5Y Monthly) 1.09
  • PE Ratio (TTM) --
  • EPS (TTM) -7.8800
  • Earnings Date May 13, 2024 - May 17, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.30

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company's offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

www.bioratherapeutics.com

58

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIOR

Performance Overview: BIOR

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIOR
53.50%
S&P 500
6.92%

1-Year Return

BIOR
75.19%
S&P 500
25.26%

3-Year Return

BIOR
99.17%
S&P 500
22.00%

5-Year Return

BIOR
--
S&P 500
64.63%

Compare To: BIOR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIOR

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    22.45M

  • Enterprise Value

    54.67M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.48k

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    13.67k

  • Enterprise Value/EBITDA

    -0.48

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -99.04%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4k

  • Net Income Avi to Common (ttm)

    -124.33M

  • Diluted EPS (ttm)

    -7.8800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.21M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    11.93M

Research Analysis: BIOR

Analyst Price Targets

5.60
10.30 Average
0.6277 Current
15.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: BIOR

Fair Value

0.6277 Current
 

Dividend Score

0 Low
BIOR
Sector Avg.
100 High
 

Hiring Score

0 Low
BIOR
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
BIOR
Sector Avg.
100 High
 

People Also Watch